Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,254,412
+$347,263 QoQ
Shares Held
36,439
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,160
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOWEN HANES & CO INC holds $152,182,717 across 7 Drug Manufacturers - General names. JNJ ranks #2 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
114,646 | $137,509,863 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
36,439 | $9,254,412 | |
| 3 | ABBV |
AbbVie Inc.
|
12,440 | $3,130,401 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
16,445 | $947,560 | |
| 5 | PFE |
Pfizer Inc
|
35,984 | $866,494 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,204 | $283,214 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,510 | $190,773 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,254,412 | 36,439 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,907,149 | 36,439 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,951,846 | 38,424 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $7,156,099 | 38,594 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,841,771 | 38,244 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,393,795 | 38,554 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,878,224 | 40,646 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $6,641,380 | 40,981 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,391,722 | 43,731 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $8,061,995 | 50,964 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $41,235,942 | 263,085 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $42,909,125 | 275,500 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $45,848,212 | 276,995 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $42,771,785 | 275,947 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $52,918,510 | 299,567 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $48,356,683 | 296,013 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $51,789,962 | 291,758 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $49,395,773 | 278,710 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $48,246,016 | 282,025 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $58,090,581 | 359,694 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $59,715,943 | 362,486 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $60,228,687 | 366,466 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $57,514,206 | 365,448 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $54,298,471 | 364,713 | Shares | Sole | 2021-02-08 | |
| 2020-06-30 | $50,918,466 | 362,074 | Shares | Sole | 2021-02-08 | |
| 2020-03-31 | $47,929,195 | 365,509 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||